Abstract
Purpose
Uveal melanoma (UM) is an intraocular malignancy commonly arising from choroid which can cause visual loss or metastasis. Ataxia-telangiectasia mutated (ATM) protein is an activator of DNA damage response and its role in uveal melanoma (UM) is still unexplored. Therefore, the study aims to detect the expression and localization of ATM protein and its association with clinicopathological parameters
Methods
Expression of nuclear ATM (nATM) was investigated on 69 formalin fixed paraffin embedded choroidal melanoma samples by immunohistochemistry and validated by western blotting. Results were then correlated with clinical and histopathological parameters. Prognostic significance was determined by the Kaplan–Meier analysis and the multivariate analysis by Cox’s hazard proportional method.
Results
Loss of nATM was observed in 65% of cases, which was statistically significant with the reduced disease-free survival (p = 0.042). This loss was more frequently found in cases with high-risk histopathological factors like epithelioid cell type, tumor infiltrating lymphocytes and high pigmentation which might help in the progression of melanoma. On multivariate analysis, extraocular spread and loss of nATM were found to be independent prognostic factors (p < 0.05).
Conclusion
Our data suggest that loss of nATM protein might serve as a poor prognostic marker in the pathogenesis of uveal melanoma which may lead to increased risk of metastasis.
Similar content being viewed by others
References
Damato B, Eleuteri A, Taktak AF et al (2011) Estimating prognosis for survival after treatment of choroidal melanoma. Prog Retin Eye Res 30:285–295
Eagle RC (2013) The pathology of ocular cancer. Eye 27:128–136
Carvajal RD, Schwartz GK, Tezel T et al (2016) Metastatic disease from uveal melanoma: treatment options and future prospects. Br J Ophthalmol 101:38–44
Salimi M, Mozdarani H, Majidzadeh K (2011) Expression pattern of ATM and cyclin D1 in ductal carcinoma, normal adjacent and normal breast tissues of Iranian breast cancer patients. Med Oncol 29:1502–1509
Maréchal A, Zou L (2013) DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb Perspect Biol 5:9
Khanna KK (2000) Cancer risk and the ATM gene: a continuing debate. J Natl Cancer Inst 92:795–802
Forbes SA, Beare D, Gunasekaran P et al (2015) COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res 43:805–811
Beggs AD, Domingo E, McGregor M et al (2012) Loss of expression of the double strand break repair protein ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN. Oncotarget 3:1348–1355
Bueno RC, Canevari RA, Villacis RAR et al (2013) ATM down-regulation is associated with poor prognosis in sporadic breast carcinomas. Ann Oncol 25:69–75
Kang B, Guo RF, Tan XH et al (2008) Expression status of ataxia-telangiectasia-mutated gene correlated with prognosis in advanced gastric cancer. Mutat Res 638:17–25
Sundar R, Miranda S, Rodrigues DN et al (2018) Ataxia telangiectasia mutated protein loss and benefit from oxaliplatin-based chemotherapy in colorectal cancer. Clin Colorectal Cancer 17:280–284
Bhandaru M, Martinka M, McElwee KJ et al (2015) Prognostic significance of nuclear phospho-ATM expression in melanoma. PLoS ONE 10(8):e0134678
Kashyap S, Venkatesh P, Sen S et al (2014) Clinicopathologic characteristics of choroidal melanoma in a North Indian population: analysis of 10-year data. Int Ophthalmol 34:235–239
The AJCC Ophthalmic Oncology Task Force (2015) International validation of the American Joint Committee on Cancer’s 7th edition classification of uveal melanoma. JAMA Ophthalmol 133:376–383
Trocme E, Mougiakakos D, Johansson CC et al (2012) Nuclear HER3 is associated with favorable overall survival in uveal melanoma. Int J Cancer 130:1120–1127
Terai M, Mastrangleo MJ, Sato T (2017) Immunological aspect of the liver and metastatic uveal melanoma. J Cancer Metastasis Treat 3:231–243
Kim H, Saka B, Knight S et al (2014) Having pancreatic cancer with tumoral loss of ATM and normal TP53 protein expression is associated with a poorer prognosis. Clin Cancer Res 20:1865–1872
Kim JW, Im SA, Kim MA et al (2014) Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker. Int J Cancer 134:72–80
Eller MS, Yaar M, Gilchrest BA (1994) DNA damage and melanogenesis. Nature 372:413–414
Lee HE, Han N, Kim MA et al (2014) DNA damage response-related proteins in gastric cancer: ATM, Chk2 and p53 expression and their prognostic value. Pathobiology 81:25–35
Abdel-Fatah TM, Arora A, Alsubhi N et al (2014) Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohorts. Neoplasia 16:982–991
Shields CL, Sioufi K, Robbins JS et al (2018) Large uveal melanoma (≥ 10 mm thickness): clinical features and millimeter-by-millimeter risk of metastasis in 1311 cases. The 2018 Albert E. Finley lecture. Retina. https://doi.org/10.1097/IAE.0000000000002144
Diener-West M, Hawkins BS, Markowitz JA et al (1992) A review of mortality from choroidal melanoma. II. A meta-Analysis of 5-year mortality rates following enucleation, 1966 through 1988. JAMA Ophthalomol 1992(110):245–250
Mouw KW, Goldberg MS, Konstantinopoulos PA et al (2017) DNA damage and repair biomarkers of immunotherapy response. Cancer Discov 7:675–693
Acknowledgements
Jayanti Jha is thankful to the Indian Council of Medical Research for providing Research Assistant (RA). We are supported by Mr. Pankaj Kumar for providing technical support in IHC.
Funding
This work supported by the Indian Council of Medical Research (ICMR), New Delhi (ICMR File no: 5/13/17/2014-NCD-III).
Author information
Authors and Affiliations
Contributions
JJ executed the study, data analysis and in association with SK; MKS contributed to the design and draft of the manuscript. LS helped in the experiments and coordination of the manuscript. NP and MSB provide the enucleated specimens. SS and SK were responsible for histopathological examination. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Jha, J., Singh, M.K., Singh, L. et al. Prognostic relevance of ATM protein in uveal melanoma and its association with clinicopathological factors. Int J Clin Oncol 24, 1526–1535 (2019). https://doi.org/10.1007/s10147-019-01519-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-019-01519-6